title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Annexon Highlights Strategic Focus to Advance Four Flagship Complement Programs through Late-Stage Development and Progress Across Three Therapeutic Franchises,20230108T140000,https://www.globenewswire.com/news-release/2023/01/08/2584729/0/en/Annexon-Highlights-Strategic-Focus-to-Advance-Four-Flagship-Complement-Programs-through-Late-Stage-Development-and-Progress-Across-Three-Therapeutic-Franchises.html,DNOW,0.017573,Neutral,0.027852
Annexon Highlights Strategic Focus to Advance Four Flagship Complement Programs through Late-Stage Development and Progress Across Three Therapeutic Franchises - Annexon  ( NASDAQ:ANNX ) ,20230108T140000,https://www.benzinga.com/pressreleases/23/01/g30323708/annexon-highlights-strategic-focus-to-advance-four-flagship-complement-programs-through-late-stage,DNOW,0.017357,Neutral,0.026098
